Product Description: Fananserin (RP 62203) is an orally bioavailable, potent and selective 5-hydroxytryptamine2 (5-HT2) receptor antagonist, with a Ki of 0.37 nM for the rat 5-HT2A receptor. Fananserin also is a selective dopamine D4 receptor antagonist, with a Ki of 2.93 nM for the human dopamine D4 receptor[1].
Applications: Neuroscience-Neuromodulation
Formula: C23H24FN3O2S
References: [1]Heuillet E, et al. The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor. Eur J Pharmacol. 1996 Oct 24;314(1-2):229-33./[2]Malgouris C, et al. Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. In vitro and ex vivo selectivity profile. Eur J Pharmacol. 1993 Mar 16;233(1):29-35./[3]Stutzmann JM, et al. RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in rats. Sleep. 1992 Apr;15(2):119-24.
CAS Number: 127625-29-0
Molecular Weight: 425.52
Compound Purity: 99.97
Research Area: Neurological Disease
Solubility: DMSO : 100 mg/mL (ultrasonic)
Target: 5-HT Receptor;Dopamine Receptor
English
Deutsch
